Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.65B |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$6.34B |
| 3 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.28B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.36B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.04B |
Top Sells
| 1 |
Texas Instruments
TXN
|
+$387M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$272M |
| 4 |
Medtronic
MDT
|
+$249M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| 1 | Technology | 21.37% |
| 2 | Financials | 10.65% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Vanda Pharmaceuticals
VNDA
$265M
| $3.35M | ﹤0.01% |
592,737
-75,443
| -11% | -$426K |
|
2527
TETRA Technologies
TTI
$640M
| $3.35M | ﹤0.01% |
967,855
+25,139
| +3% | +$87K |
|
|
TELL
2528
DELISTED
Tellurian Inc.
TELL
| $3.3M | ﹤0.01% |
4,768,144
-551,645
| -10% | -$382K |
|
2529
Tejon Ranch
TRC
$451M
| $3.29M | ﹤0.01% |
192,984
+3,913
| +2% | +$66.8K |
|
2530
Adaptive Biotechnologies
ADPT
$2.05B
| $3.28M | ﹤0.01% |
906,481
+36,699
| +4% | +$133K |
|
2531
SandRidge Energy
SD
$429M
| $3.28M | ﹤0.01% |
253,533
+4,612
| +2% | +$59.6K |
|
2532
Bandwidth Inc
BAND
$458M
| $3.27M | ﹤0.01% |
193,572
+11,218
| +6% | +$189K |
|
2533
HilleVax
HLVX
$105M
| $3.25M | ﹤0.01% |
224,867
+18,601
| +9% | +$269K |
|
2534
British American Tobacco
BTI
$125B
| $3.25M | ﹤0.01% |
105,008
+24,961
| +31% | +$772K |
|
2535
Janux Therapeutics
JANX
$1.46B
| $3.25M | ﹤0.01% |
77,516
+28,258
| +57% | +$1.18M |
|
2536
Eventbrite
EB
$261M
| $3.21M | ﹤0.01% |
662,886
+5,374
| +0.8% | +$26K |
|
2537
Playtika
PLTK
$1.38B
| $3.2M | ﹤0.01% |
406,946
+9,230
| +2% | +$72.6K |
|
2538
Northfield Bancorp
NFBK
$487M
| $3.18M | ﹤0.01% |
335,649
-2,379
| -0.7% | -$22.6K |
|
|
ITOS
2539
DELISTED
iTeos Therapeutics
ITOS
| $3.17M | ﹤0.01% |
213,738
+7,873
| +4% | +$117K |
|
2540
OraSure Technologies
OSUR
$238M
| $3.16M | ﹤0.01% |
742,639
-32,989
| -4% | -$141K |
|
2541
Ouster
OUST
$1.78B
| $3.16M | ﹤0.01% |
321,664
+127,645
| +66% | +$1.25M |
|
2542
Erasca
ERAS
$440M
| $3.15M | ﹤0.01% |
1,333,421
+669,551
| +101% | +$1.58M |
|
2543
Humacyte
HUMA
$238M
| $3.14M | ﹤0.01% |
654,372
+180,605
| +38% | +$867K |
|
|
SAVE
2544
DELISTED
Spirit Airlines, Inc.
SAVE
| $3.13M | ﹤0.01% |
856,488
+51,996
| +6% | +$190K |
|
2545
Banco Bilbao Vizcaya Argentaria
BBVA
$110B
| $3.13M | ﹤0.01% |
311,678
+36,641
| +13% | +$368K |
|
2546
SelectQuote
SLQT
$339M
| $3.11M | ﹤0.01% |
1,128,504
+44,674
| +4% | +$123K |
|
2547
Futu Holdings
FUTU
$25.9B
| $3.11M | ﹤0.01% |
47,448
+11,698
| +33% | +$767K |
|
2548
Vivid Seats
SEAT
$96.5M
| $3.11M | ﹤0.01% |
27,067
+1,397
| +5% | +$161K |
|
2549
Cardlytics
CDLX
$61.2M
| $3.11M | ﹤0.01% |
378,955
+61,836
| +19% | +$508K |
|
|
AVDL
2550
Avadel Pharmaceuticals
AVDL
$1.54B
| $3.1M | ﹤0.01% |
+220,701
| New | +$3.1M |
|